Dr. Sameer Mohammad

Research Scientist and Principal Investigator
King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

Highest Degree
Ph.D. in Biochemistry and Experimental Biology from Jawaharlal Nehru University, New Delhi, India

My URL
https://livedna.org/91.39026

Share this Profile

Area of Interest:

Biomedical Sciences
Biochemistry
Experimental Biology
Molecular Biology
Animal Models

Selected Publications

  1. Al Mahri, S., S.S. Malik, M. Al Ibrahim, E. Haji, G. Dairi and S. Mohammad, 2022. Free Fatty Acid Receptors (FFARs) in adipose: Physiological role and therapeutic outlook. Cells, Vol. 11. 10.3390/cells11040750 .
    CrossRef  |  Direct Link  |  

  2. Mohammad, S., R. Aziz, S. Al Mahri, S.S. Malik and E. Haji et al., 2021. Obesity and COVID-19: what makes obese host so vulnerable? Immun. Ageing, Vol. 18. 10.1186/s12979-020-00212-x.
    CrossRef  |  Direct Link  |  

  3. Haji, E., S. Al Mahri, Y. Aloraij, S.S. Malik and S. Mohammad, 2021. Functional characterization of the obesity-linked variant of the β3-adrenergic receptor. Int. J. Mol. Sci., Vol. 22. 10.3390/ijms22115721.
    CrossRef  |  Direct Link  |  

  4. Gupta, M.K., M. Beg and S. Mohammad, 2021. Editorial: Cell biology, physiology and molecular pharmacology of G protein coupled receptors. Front. Cell Dev. Biol., Vol. 9. 10.3389/fcell.2021.815291.
    CrossRef  |  Direct Link  |  

  5. Mohammad, S., A. Bouchama, B.M. Alharbi, M. Rashid, T.S. Khatlani, N.S. Gaber and S.S. Malik, 2020. SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic divergence and functional convergence. Pathogens, Vol. 9. 10.3390/pathogens9090677.
    CrossRef  |  Direct Link  |  

  6. Haji, E., S. Al Mahri, Y. Aloraij, S. Malik and S. Mohammad, 2019. Single-cell analysis of β2-adrenergic receptor dynamics by quantitative fluorescence microscopy. Curr. Mol. Med., 20: 488-493.
    CrossRef  |  Direct Link  |  

  7. Alhawiti, N.M., S. Al Mahri, M.A. Aziz, S.S. Malik and S. Mohammad, 2017. TXNIP in metabolic regulation: Physiological role and therapeutic outlook. Curr. Drug Targets, 18: 1095-1103.
    CrossRef  |  Direct Link  |  

  8. Mohammad, S., 2016. GPR40 agonists for the treatment of type 2 diabetes mellitus: Benefits and challenges. Curr. Drug Targets, 17: 1292-1300.
    CrossRef  |  Direct Link  |  

  9. Mohammad, S., 2015. Role of free fatty acid receptor 2 (FFAR2) in the regulation of metabolic homeostasis. Curr. Drug Targets, 16: 771-775.
    CrossRef  |  Direct Link  |  

  10. Mohammad, S., R.T. Patel, J. Bruno, M.S. Panhwar, J. Wen and T.E. McGraw, 2014. A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity. Mol. Cell. Biol., 34: 3618-3629.
    CrossRef  |  Direct Link  |  
Member since October, 2022